HCM
LSBPW

Highbridge Capital Management’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Highbridge Capital Management’s Portfolio LSBPW Stock Details LSBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Hold
0
– -$13.2K – 332
2024
Q3 		– Hold
0
– – – 303
2024
Q2 		– Hold
0
– – – 281
2024
Q1 		– Hold
0
– – – 254
2023
Q4 		– Hold
0
– – – 297
2023
Q3 		– Hold
0
– – – 347
2023
Q2 		– Hold
0
– – – 337
2023
Q1 		– Hold
0
– – – 264

Other funds holding LSBPW

LP
LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $122M AUM
FC
Finepoint Capital Boston, Massachusetts $417M AUM 45.61% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $556M AUM 33.02% 1-Year Est. Return
OCM
Ovata Capital Management Hong Kong $715M AUM 19.57% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $25.9B AUM 21.78% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $104M AUM 20.91% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $6.95B AUM 15.85% 1-Year Est. Return